-- Jazz Pharmaceuticals Shares Decline on Offering of 7.88 Million Shares
-- B y   M e g   T i r r e l l
-- 2012-03-06T21:08:39Z
-- http://www.bloomberg.com/news/2012-03-06/jazz-pharmaceuticals-shares-decline-on-offering-of-7-88-million-shares.html
Jazz Pharmaceuticals Plc (JAZZ) , maker of
the narcolepsy medicine Xyrem, declined in New York trading
after the company reported a public offering of 7.88 million
shares by some stockholders.  Jazz dropped 5.1 percent to $48.72 at 4 p.m. The shares of
the Dublin-based company have gained 80 percent in the last 12
months. The drugmaker also has offices in  Palo Alto , California,
and Philadelphia.  Barclays Plc and Citigroup Inc. are leading the offering,
Jazz said yesterday in a statement. The company won’t receive
any proceeds from the sale, and the total number of shares
outstanding won’t change.  To contact the reporter on this story:
Meg Tirrell in New York at 
 mtirrell@bloomberg.net   To contact the editor responsible for this story:
Reg Gale at 
 rgale5@bloomberg.net  